JPMorgan’s top biopharma picks for 2025

The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.

Leave a Reply

Your email address will not be published. Required fields are marked *